1996
DOI: 10.1002/j.1460-2075.1996.tb00388.x
|View full text |Cite
|
Sign up to set email alerts
|

A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human beta-globin locus control region.

Abstract: Single‐copy human beta‐globin transgenes are very susceptible to suppression by position effects of surrounding closed chromatin. However, these position effects are overcome by a 20 kbp DNA fragment containing the locus control region (LCR). Here we show that the 6.5 kbp microlocus LCR cassette reproducibly directs full expression from independent single‐copy beta‐globin transgenes. By testing individual DNase I‐hypersensitive sites (HS) present in the microlocus cassette, we demonstrate that the 1.5 kbp 5′HS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
162
1
6

Year Published

1997
1997
2013
2013

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 215 publications
(180 citation statements)
references
References 48 publications
11
162
1
6
Order By: Relevance
“…Our observation that single copies of the integrated HS2 sequence possess enhancer function is in agreement with similar findings in K562 cells reported by other investigators (31,54). However, it has been reported recently that single copies of the HS2 sequence integrated into the fetal liver erythroid cells of transgenic mice did not exhibit enhancer activity (13). This apparently discordant observation may be due to the relative inactivity of the HS2 enhancer in fetal liver erythroid cells, since the HS2 site, as compared with the HS3 site, exists in a relatively inaccessible chromatin structure in fetal liver erythroid cells (17), whereas it exists in a more accessible chromatin structure in K562 cells (50,56).…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Our observation that single copies of the integrated HS2 sequence possess enhancer function is in agreement with similar findings in K562 cells reported by other investigators (31,54). However, it has been reported recently that single copies of the HS2 sequence integrated into the fetal liver erythroid cells of transgenic mice did not exhibit enhancer activity (13). This apparently discordant observation may be due to the relative inactivity of the HS2 enhancer in fetal liver erythroid cells, since the HS2 site, as compared with the HS3 site, exists in a relatively inaccessible chromatin structure in fetal liver erythroid cells (17), whereas it exists in a more accessible chromatin structure in K562 cells (50,56).…”
Section: Discussionsupporting
confidence: 93%
“…Because of the concerns that the HS2 enhancer may be active only when it is integrated in multiple tandem copies (13) and that the subsequently detected HS2 transcripts are therefore not RNA transcribed from the HS2 in each individual plasmid but are nonspecific readthrough transcripts of the tandemly integrated upstream plasmids, we also transfected a number of the plasmids by a modified calcium phosphate method in an attempt to integrate the plasmids in single copies into K562 cells (see Materials and Methods). For purpose of comparison, a number of plasmids were also transfected by the electroporation method.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the ␤:6 mice, the values of expression level per copy varied over a range of 11-fold in the thymus, 4-fold in spleen, 5-fold in heart, and 6-fold in liver. These values are well within the range described for the activity of a "partial-LCR" (27). In contrast, in the ␤:⌬6 mice, the range of variation in expression level per copy was over 110-fold in thymus, 190-fold in spleen, 56-fold in heart, and 150-fold in liver.…”
Section: Hs6 Protects the Transgene From Expression-level Variabilitysupporting
confidence: 83%
“…Nevertheless, their effect on transgene expression in the chromatin of the whole animal is now well documented. Such elements include HS3 of the ␤-globin LCR (27), HSS3 of the CD2 LCR (44), and the facilitator elements of the adenosine deaminase LCR (38). We have also recently described such an element in the TCR␣ LCR.…”
Section: Discussionmentioning
confidence: 99%